110 results
DEFA14A
PYXS
Pyxis Oncology Inc
26 Apr 24
Additional proxy soliciting materials
4:16pm
Flavin 1.03 Lara Sullivan,M.D. 1.04 Jakob Dupont,M.D. 2. The ratification of the appointment of Ernst & Young LLP as our independent registered public
424B2
PYXS
Pyxis Oncology Inc
3 Apr 24
Prospectus for primary offering
8:45pm
, and that our internal controls over financial reporting be audited by our independent registered public accounting firm pursuant to Section 404 … , independent registered public accounting firm, has audited our consolidated financial statements included in our Annual Report on Form 10-K
8-K
a92kv0c tj
13 Mar 24
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
4:31pm
8-K
EX-10.2
fayod45 cj9d
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K
EX-10.1
296trt6fkyw o0
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K
EX-4.1
bkznwjyn35n89p fr
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K/A
EX-99.1
ama1fe
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
8-K/A
EX-23.1
ysjm 3geqkxx
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
S-8 POS
EX-23.2
2lkl72
23 Aug 23
Registration of securities for employees (post-effective amendment)
5:30pm
S-8 POS
EX-5.1
33igvtn n97i0fxr9
23 Aug 23
Registration of securities for employees (post-effective amendment)
5:30pm